chr9-134642049-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_000093.5(COL5A1):c.-139G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000336 in 701,472 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00035 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00033 ( 0 hom. )
Consequence
COL5A1
NM_000093.5 5_prime_UTR_premature_start_codon_gain
NM_000093.5 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.813
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000349 (53/151970) while in subpopulation AMR AF= 0.00144 (22/15272). AF 95% confidence interval is 0.000975. There are 0 homozygotes in gnomad4. There are 30 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 53 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL5A1 | NM_000093.5 | c.-139G>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/66 | ENST00000371817.8 | NP_000084.3 | ||
COL5A1 | NM_000093.5 | c.-139G>T | 5_prime_UTR_variant | 1/66 | ENST00000371817.8 | NP_000084.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL5A1 | ENST00000371817 | c.-139G>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/66 | 1 | NM_000093.5 | ENSP00000360882.3 | |||
COL5A1 | ENST00000371817 | c.-139G>T | 5_prime_UTR_variant | 1/66 | 1 | NM_000093.5 | ENSP00000360882.3 | |||
COL5A1 | ENST00000371820 | c.-139G>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/66 | 2 | ENSP00000360885.4 | ||||
COL5A1 | ENST00000371820 | c.-139G>T | 5_prime_UTR_variant | 1/66 | 2 | ENSP00000360885.4 |
Frequencies
GnomAD3 genomes AF: 0.000349 AC: 53AN: 151970Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
53
AN:
151970
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000333 AC: 183AN: 549502Hom.: 0 Cov.: 8 AF XY: 0.000332 AC XY: 89AN XY: 268400
GnomAD4 exome
AF:
AC:
183
AN:
549502
Hom.:
Cov.:
8
AF XY:
AC XY:
89
AN XY:
268400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000349 AC: 53AN: 151970Hom.: 0 Cov.: 32 AF XY: 0.000404 AC XY: 30AN XY: 74204
GnomAD4 genome
AF:
AC:
53
AN:
151970
Hom.:
Cov.:
32
AF XY:
AC XY:
30
AN XY:
74204
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Ehlers-Danlos syndrome type 7A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at